SCHEMBL7495451

SCHEMBL7495451

COc1cc2c(C)nc(OC(C)=O)c(N(C(C)=O)C(C)=O)c2cc1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNFSF11 O14788 1/20 0.39
KDM4E B2RXH2 1/20 0.38
NR3C1 P04150 1/20 0.36
PDE10A Q9Y233 1/20 0.36
TSHR P16473 1/20 0.35
PDE3B Q13370 2/20 0.35
PDE3A Q14432 2/20 0.35
POLB P06746 2/20 0.33
RAC1 P63000 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33
AMY1A P0DUB6 2/20 0.33
GABRA1 P14867 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRA6 Q16445 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7439631 0.75 MAPT (0.40) TNFSF11KDM4ENR3C1PDE10APOLB
SCHEMBL11971454 0.70 RAC1 (0.46) TNFSF11KDM4ENR3C1TSHRPOLB
SCHEMBL7446369 0.69 MEN1 (0.40) KDM4EPDE3BPDE3APOLBNPSR1
SCHEMBL7426725 0.66 LMNA (0.43) KDM4EPDE10ANPSR1MEN1GAA
SCHEMBL12325390 0.65 CYP3A4 (0.46) KDM4ETSHRPDE3BPDE3APOLB
SCHEMBL11971521 0.63 KDM4E (0.51) KDM4EPDE10APDE3BPDE3APOLB
SCHEMBL18937049 0.63 ALOX5 (0.35) KDM4ETSHRPOLBNPSR1HSD17B10
SCHEMBL21723164 0.62 TNFSF11 (0.83) TNFSF11KDM4ENR3C1TSHRGAA
SCHEMBL27602532 0.62 TNFSF11 (0.83) TNFSF11KDM4ENR3C1TSHRGAA
SCHEMBL8928654 0.62 TNFSF11 (0.83) TNFSF11KDM4ENR3C1TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4880817-A O-functionalized derivatives of substituted isoquinolin-3-ols having cardiotonic and/or phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-11-14 US disclosed